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 The formation of C–C bonds from unactivated alkyl electrophiles has been 
extensively investigated, but methods to form analogous C–heteroatom bonds are far less 
developed. The first cross-coupling reaction of unactivated secondary and tertiary alkyl 
electrophiles to form C–Si bonds is described. Using a commercially available nickel 
complex NiBr2·diglyme, a variety of alkyl bromides efficiently undergo cross-coupling with 
silylzinc reagents at low temperature. This nickel-catalyzed silylation method represents a 
rare example of employing unactivated tertiary alkyl halides as electrophilic coupling 
partners. Additionally, the versatility of this reaction is demonstrated through compatibility 
with different classes of silicon nucleophiles. Stereochemical studies and relative reactivity 





 Beyond their role as synthetic intermediates,1 organosilicon compounds exhibit 
diverse applications in fields ranging from materials science2 to agrochemistry3 to medicinal 
chemistry.4 Silicon-containing agrochemicals have reached broad commercial application 
due to their function as antifungals and insecticides. Furthermore, the introduction of silicon 




medicinal chemists. However, the synthesis of these compounds is limited by several factors. 
Tetraorganosilanes are typically prepared either through the hydrosilylation of olefins 
(Figure 2.1(a)), where issues of reactivity (e.g., hindered substrates) and regioselectivity 
(e.g., 1,2-disubstituted olefins) can present significant challenges,5,6 or through the reaction 
of an organic nucleophile with a silicon electrophile (Figure 2.1(b)),7 for which general 
methods are limited to primary alkyl nucleophiles.8 In principle, the coupling of an alkyl 
electrophile with a silicon nucleophile (Figure 2.1(c)) could provide a general approach for 
the synthesis of tetraorganosilanes; however, progress in developing this reaction has been 
rather limited, especially with respect to catalyzed processes. Indeed, to the best of our 
knowledge, catalyzed methods have been restricted to couplings of activated alkyl 
electrophiles (e.g., allylic, benzylic, and propargylic),9 with the exception of two reports of 
the cross-coupling of unactivated primary alkyl electrophiles.10,11 
 
 
Figure 2.1. Three approaches to the synthesis of tetraorganosilanes. 
  
 Over the past decade, significant progress has been made toward developing catalytic 
cross-coupling reactions of alkyl electrophiles to generate C−C bonds.12 However, similar 
transformations to generate bonds to heteroatoms are far less common. As part of an ongoing 
effort to broaden the scope of cross-couplings of alkyl electrophiles, we recently reported our 
first nickel-catalyzed C−X bond-forming process, the Miyaura borylation of primary, 
secondary, and tertiary alkyl halides.13,14 Drawing inspiration from this transformation, we 
turned our attention to a related silylation reaction. Specifically, we establish that a 
commercially available nickel catalyst, without an added ligand, catalyzes the cross-coupling 
of unactivated secondary and tertiary alkyl bromides with silylzinc nucleophiles (Eq. 2.1).  
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poor regioselectivity for typical 
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 During initial studies, we applied our previously discovered borylation reaction 
conditions to an analogous silylation reaction involving a silylboron reagent, hoping to 
achieve similar reactivity.13 Unfortunately, only trace levels of C−Si bond formation were 




 After exploring various reaction parameters with a monosilylzinc halide16 serving as 
the nucleophile, we were delighted to find that NiBr2·diglyme could catalyze the silylation 
reaction of a model unactivated secondary alkyl bromide with PhMe2Si–ZnCl in good yield 
(Table 2.1, entry 1). As shown in Table 2.1, no C–Si bond formation is observed in the 
absence of NiBr2·diglyme (entry 2). Under these conditions, other classes of silicon 
nucleophiles tested are not effective coupling partners (entries 3 and 4). Additionally, other 
selected transition metal complexes (Fe, Co, Cu, and Pd) are not able to facilitate the reaction 
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the desired product (entry 9).18 A reduction in yield occurs when the reaction is performed 
with lower catalyst loading, less nucleophile, and at room temperature (entries 10–12). 
Interestingly, the silylation is only moderately sensitive to air (entry 13) and very tolerant of 
water (entry 14). This is the first nickel-catalyzed cross-coupling reaction of alkyl 
electrophiles reported by the Fu laboratory that does not use an added ligand.  
   
Table 2.1. Silylation of a Model Unactivated Secondary Bromide: Effect of Reaction 
Parameters 
 
aYields were deteremined by GC analysis with the aid of a calibrated standard (averages of 
two experiments).  
 
 
Scope with Respect to the Electrophile 
 
With the optimized conditions in hand, we next investigated the electrophile scope. The 
commercially available catalyst NiBr2·diglyme can be used for the silylation of an array of 
unactivated secondary alkyl bromides at –20 ºC (Table 2.2). In addition to the model 
electrophile (entry 1) used for optimization, sterically hindered a-branched substrates such  
1.5 equiv
none
no NiBr2 •  diglyme
Li–SiMe2Ph, instead of ClZn–SiMe2Ph
ClMg–SiMe2Ph, instead of ClZn–SiMe2Ph
FeCl2, instead of NiBr2 •  diglyme
CoCl2, instead of NiBr2 •  diglyme
CuBr •  SMe2, instead of NiBr2 •  diglyme
Pd(MeCN)2Cl2, instead of NiBr2 •  diglyme
no DMA
0.5 mol% NiBr2 •  diglyme
1.1 equiv ClZn–SiMe2Ph
r.t., instead of –20 °C
under air in a closed vial
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Table 2.2. Silylation of Unactivated Secondary Alkyl Bromides: Scope 
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as an iso-propyl (entry 2) and even a tert-butyl (entry 3) substituted alkyl bromide are useful 
coupling partners. A variety of functional groups, including a trifluoromethyl group (entry 
4), a carbamate (entry 5), a tertiary amine (entry 6), a sulfonamide (entry 7), and an aryl 
chloride (entry 8) are well suited for this reaction. Furthermore, heterocycles such as furan 
(entry 9) and indole (entry 10) enable efficient C–Si bond formation. These functionalized 
electrophiles include sensitive groups that are incompatible with the formation of alkyl 
nucleophiles used in the reaction shown in Figure 2.1(b).19 Initial studies investigating an 
alkyl bromide containing thiophene, a secondary alkyl choride, and an alkyl tosylate showed 
that these are not useful coupling partners under the standard conditions. 
 While the standard reaction conditions did not facilitate C–Si bond formation with 
secondary alkyl chlorides, an unactivated secondary alkyl iodide was an effective 
electrophile (Eq. 2.3).20 Additionally, this method is adaptable to scale-up, and the cross-
coupling reaction shown in Table 2.2, entry 1 can be performed with reduced catalyst loading 




 Tertiary alkyl electrophiles are known to be challenging substrates, and reports of 
unactivated tertiary alkyl electrophiles in cross-coupling reactions have been limited.21 Thus, 
we were excited to find that the optimized conditions allow for the coupling of unactivated 
tertiary alkyl bromides (Table 2.3) in addition to secondary alkyl bromides. Both acyclic 
(entries 1–3) and cyclic (entries 4–6) substrates are compatible under the standard conditions. 















NiBr2 •  diglyme





Table 2.3. Silylation of Unactivated Tertiary Alkyl Bromides: Scope 
 
aYields of purified products (averages of two experiments). bCatalyst loading: 2.0% 
NiBr2·diglyme.  
 
In addition to the tertiary alkyl bromides shown in Table 2.3, a preliminary attempt 
to silylate 3-iodoadamantane under the standard conditions provided a promising result 
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Scope with Respect to the Nucleophile 
 
 Following investigations demonstrating that the scope of this new silylation reaction 
is broad with respect to secondary and tertiary alkyl electrophiles, we next evaluated the 
compatibility of other silicon nucleophiles. The simple nickel catalyst facilitates C–Si bond 
formation with silylzinc reagents containing one, two, and three aryl substituents with high 






 Previous studies of nickel-catalyzed cross-couplings of unactivated alkyl halides to 
generate C–C and C–B bonds from the Fu laboratory have suggested that alkyl electrophiles 
can undergo oxidative addition to form alkyl radical intermediates.13,23 Our studies of this 
new C–Si bond forming reaction suggest that oxidative addition occurs by a similar radical 
mechanism. In the reactions of exo- and endo-2-bromonorbornane, the same diastereomeric 
mixture of products is formed (7:1 exo:endo; each alkyl bromide remains a single 
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in the two reactions (Eqs. 2.6 and 2.7).24 Furthermore, the addition of 2,2,6,6-
tetramethylpiperidin-1-oxyl (TEMPO),25 which rapidly traps alkyl radicals, inhibits C–Si 
bond formation under our standard conditions.  
 Inspired by the fact that unactivated tertiary alkyl electrophiles are effecting coupling 
partners under our standard conditions, we conducted competition experiments between a 
tertiary, a secondary, and a primary alkyl bromide (Eqs. 2.8 and 2.9). Electrophiles with 
higher degrees of substitution demonstrate higher levels of reactivity (tertiary > secondary > 
primary).26 This result is consistent with the stability of the radical, rather than steric effects, 
being the dominant factor influencing relative reactivity, providing further evidence for the 






 We have described the first cross-coupling reaction of unactivated secondary and 
tertiary alkyl electrophiles to form C−Si bonds. Using only a commercially available nickel 
catalyst, we have observed efficient cross-coupling of a variety of silylzinc nucleophiles with 
both secondary and tertiary alkyl bromides, demonstrating good tolerance of both steric bulk 
as well as diverse functional groups. Competition experiments suggest that tertiary alkyl 
bromides are more reactive than secondary or primary alkyl bromides. Preliminary 
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 Anhydrous THF was purified and dried using a solvent-purification system that 
contained activated alumina.  The following reagents and solvents were purchased and used 
as received: lithium metal (granular, 4-10 mesh particle size, 99%; Aldrich), zinc chloride 
(≥98%; Aldrich), dimethylphenylchlorosilane (TCI), chloro(methyl)diphenylsilane 
(Aldrich), chlorotriphenylsilane (Acros), NiBr2·diglyme (Aldrich), dimethylacetamide 
(≥99%, over molecular sieves; Aldrich), triphenylphosphine (Aldrich), bromine (Aldrich), 
imidazole (Aldrich), LiBr (≥99%; Aldrich), and N-Boc-4-bromopiperidine (Aldrich).  All 
other alkyl bromides were prepared from the corresponding alcohols according to General 
Procedure A or B. 
 1H and 13C NMR spectroscopic data were collected on a Varian 500 MHz 
spectrometer at ambient temperature.  GC analyses were obtained on an Agilent 6890 Series 
GC system with a DB-1 column (length 30 m, internal diameter 0.25 mm). 
 
Preparation of Electrophiles 
 General Procedure A: Bromination of Secondary Alcohols.27 
Triphenylphosphine (1.3 equiv) and imidazole (1.3 equiv) were dissolved in dry CH2Cl2 (0.2 
M), and the resulting solution was stirred at 0 °C under a nitrogen atmosphere.  Bromine (1.3 
equiv) was added dropwise, and the reaction mixture was stirred at 0 °C for 5 min.  The 
alcohol was then added dropwise over 3 min.  The reaction mixture was allowed to warm to 
r.t., and then it was stirred for 6–12 h.  A saturated aqueous solution of NH4Cl was added to 
the reaction mixture, which was then extracted two times with Et2O.  The combined organic 
layers were dried over MgSO4, filtered, and concentrated.  The residue was purified by flash 
chromatography (Et2O/hexane). 
 General Procedure B: Bromination of Tertiary Alcohols.28 LiBr (2.0 equiv) was 
dissolved in 48 wt% aqueous HBr, and the resulting solution was cooled to 0 °C.  The alcohol 
was added at 0 °C, and the reaction mixture was allowed to warm to r.t. and stirred for 3 h.  
The mixture was then diluted with Et2O and washed once with each of the following: 




over Na2SO4, filtered, and concentrated.  The residue was purified by distillation under 
reduced pressure. 
 




 1-((3-Bromopentyl)oxy)-2-(trifluoromethyl)benzene.  The bromide was prepared 
according to General Procedure A from the corresponding alcohol, 1-(2-
(trifluoromethyl)phenoxy)pentan-3-ol.  The product was purified by flash chromatography 
(0®2% Et2O/hexane).  Pale-yellow oil (1.42 g, 90%).  
 1H NMR (500 MHz, CDCl3) δ 7.59 – 7.54 (m, 1H), 7.52 – 7.46 (m, 1H), 7.05 – 6.98 
(m, 2H), 4.33 – 4.19 (m, 3H), 2.37 (dddd, 1H, J = 15.0, 8.4, 5.8, 3.4 Hz), 2.23 (ddt, 1H, J = 
14.7, 10.0, 4.5 Hz), 2.03 – 1.87 (m, 2H), 1.10 (t, 3H, J = 7.3 Hz). 
 13C NMR (126 MHz, CDCl3) δ 156.6, 133.3, 127.1 (q, J = 5.2 Hz), 123.7 (q, J = 
272.3 Hz), 120.1, 118.8 (q, J = 30.6 Hz), 112.8, 66.4, 55.9, 38.1, 32.4, 12.0. 
 FT-IR (film) 2971, 1608, 1495, 1460, 1322, 1276, 1258, 1116, 1057, 1037,  
 754 cm-1. 
 MS (EI) m/z (M+) calcd for C12H1479BrF3O: 310, found: 310. 
 
 
 1-((3-Bromopentyl)oxy)-4-chlorobenzene.  The bromide was prepared according 
to General Procedure A from the corresponding alcohol, 1-(4-chlorophenoxy)pentan-3-ol.  
The product was purified by flash chromatography (0®2% Et2O/hexane).  Pale-yellow oil 
(1.01 g, 92%). 
 1H NMR (500 MHz, CDCl3) δ 7.27 – 7.20 (m, 2H), 6.85 – 6.80 (m, 2H), 4.23 (ddt, 
1H, J = 12.6, 8.1, 2.8), 4.17 – 4.08 (m, 2H), 2.35 – 2.25 (m, 1H), 2.25 – 2.15 (m, 1H), 2.01 











 13C NMR (126 MHz, CDCl3) δ 157.3, 129.3, 125.7, 115.8, 66.1, 55.9, 38.1, 32.4, 
12.0. 
 FT-IR (film) 2969, 2934, 2877, 1597, 1581, 1492, 1468, 1245, 823, 670 cm-1. 
 MS (EI) m/z (M+) calcd for C11H1479BrClO: 276, found: 276. 
 
 
 3-Bromobutyl furan-2-carboxylate.  The bromide was prepared according to 
General Procedure A from the corresponding alcohol, 3-hydroxylbutyl furan-2-carboxylate.  
The product was purified by flash chromatography (10% EtOAc/hexane).  Pale-yellow oil 
(1.34 g, 54%). 
 1H NMR (500 MHz, CDCl3) δ 7.57 (dd, 1H, J = 1.8, 0.9 Hz), 7.17 (dd, 1H, J = 3.5, 
0.9 Hz), 6.51 (dd, 1H, J = 3.5, 1.7 Hz), 4.53 – 4.47 (m, 1H), 4.42 (ddd, 1H, J = 11.2, 7.9, 5.7 
Hz), 4.27 (dqd, 1H, J = 9.0, 6.7, 4.5 Hz), 2.29 – 2.14 (m, 2H), 1.77 (d, 3H, J = 6.7 Hz). 
 13C NMR (126 MHz, CDCl3) δ 158.5, 146.4, 144.4, 118.1, 111.8, 62.9, 46.7, 39.7, 
26.5. 
 FT-IR (film) 2969, 1724, 1473, 1296, 1179, 1116, 885, 761 cm-1. 
 MS (EI) m/z (M+) calcd for C9H1179BrO3: 246, found: 246. 
 
 
 3-(3-Bromopentyl)-1-methyl-1H-indole.  The bromide was prepared according to 
General Procedure A from the corresponding alcohol, 1-(1-methyl-1H-indol-3-yl)pentan-3-
ol.  The product was purified by flash chromatography (5®10% EtOAc/hexane).  Pale-
yellow oil (0.86 g, 34%). 
 1H NMR (500 MHz, CDCl3) δ 7.63 (dt, 1H, J = 7.9, 1.0 Hz), 7.33 – 7.30 (m, 1H), 
7.27 – 7.23 (m, 1H), 7.15 – 7.10 (m, 1H), 6.91 (s, 1H), 4.03 (ddt, 1H, J = 8.6, 7.1, 5.2 Hz), 
3.76 (s, 3H), 3.11 – 3.02 (m, 1H), 2.98 – 2.89 (m, 1H), 2.27 – 2.12 (m, 2H), 1.95 – 1.85 (m, 











 13C NMR (126 MHz, CDCl3) δ 137.0, 127.7, 126.5, 121.5, 118.9, 118.6, 113.5, 
109.2, 60.3, 39.3, 32.6, 32.3, 23.2, 12.0. 
 FT-IR (film) 2933, 1473, 1377, 1325, 1249, 802, 737 cm-1. 
 MS (EI) m/z (M+) calcd for C14H1879BrN: 279, found: 281 (M++2).  
 
 
 4-Bromo-4-methylheptane.  The bromide was prepared according to General 
Procedure B from the corresponding alcohol, 4-methylheptan-4-ol.  The product was distilled 
at 35 °C under reduced pressure (5 torr).  Colorless oil (3.01 g, 81%). 
 1H NMR (500 MHz, CDCl3) δ 1.87 – 1.72 (m, 4H), 1.70 (s, 3H), 1.56 – 1.45 (m, 4H), 
0.94 (t, 6H, J = 7.3 Hz). 
 13C NMR (126 MHz, CDCl3) δ 74.1, 47.7, 31.5, 19.1, 14.1. 
 FT-IR (film) 2960, 2873, 1465, 1380, 1142, 1125, 806, 745 cm-1. 
 MS (EI) m/z (M+–Br) calcd for C8H17: 113, found: 113. 
 
 
 4-Bromo-4-butyltetrahydro-2H-pyran.  The bromide was prepared according to 
General Procedure B from the corresponding alcohol, 4-butyltetrahydro-2H-pyran-4-ol.  The 
product was distilled at 34 °C under reduced pressure (0.16 torr).  Colorless oil (3.43 g, 88%). 
 1H NMR (500 MHz, CDCl3) δ 3.88 – 3.82 (m, 4H), 1.99 – 1.92 (m, 2H), 1.90 – 1.82 
(m, 2H), 1.74 (ddd, 2H, J = 14.7, 9.2, 7.7 Hz), 1.59 – 1.51 (m, 2H), 1.41 – 1.31 (m, 2H), 0.94 
(t, 3H, J = 7.3 Hz). 
 13C NMR (126 MHz, CDCl3) δ 72.6, 64.6, 46.8, 40.6, 26.6, 22.7, 14.0. 
 FT-IR (film) 2956, 2862, 1467, 1241, 1140, 1106, 1017, 857, 813, 637 cm-1. 
 MS (EI) m/z (M+–Br) calcd for C9H17O: 141, found: 141. 
 
Nickel-Catalyzed Silylations of Unactivated Alkyl Halides 
 General procedure for the preparation of solutions of ClZn–SiMe2Ph and 










with elemental lithium (174 mg, 25 mmol, 2.5 equiv), closed with a PTFE septum cap, and 
placed under vacuum.  The vial was refilled with argon, and this evacuation-refill cycle was 
repeated three times.  THF (10 mL) was then added via syringe, an argon-filled balloon was 
attached to the vial, and the suspension was cooled to 0 °C.  The chlorosilane (10 mmol, 1.0 
equiv) was added via syringe, and then the reaction mixture was sonicated in an ice/water 
bath for 1 h, allowing the final bath temperature to reach ~10 °C.  The mixture was then 
stirred under argon at 0 °C for 12 h.  Next, the vial was warmed to r.t., and the supernatant 
was removed from the residual lithium metal and transferred via syringe to an oven-dried, 
septum-capped 40-mL vial equipped with a stir bar under a nitrogen atmosphere; the 
silyllithium was titrated against diphenylacetic acid according to Kofron’s method.30 In air, 
ZnCl2 (dried with a heat gun under high vacuum for 20 min prior to the reaction; 1.0 equiv 
with respect to titrated silyllithium) was quickly weighed into an oven-dried 8-mL vial and 
placed under vacuum.  The vial was refilled with nitrogen, and this evacuation-refill cycle 
was repeated three times.  Dry THF was then added to form an ~1.2 M solution of ZnCl2.  
This solution was added via syringe into a 40-mL vial equipped with a nitrogen-filled balloon 
that contained the silyllithium at 0 °C, and the reaction mixture was stirred at 0 °C for 30 
min.  After warming to r.t., the mixture was filtered under a nitrogen atmosphere by injecting 
it through a syringe filter directly into a nitrogen-filled, 20-mL scintillation vial sealed with 
a septum cap.  The silylzinc solution (routinely formed as an ~0.4 M solution) was titrated 
using Knochel’s method (at r.t.).31 
 These solutions of silylzinc halide reagents can be stored for 1 month without 
deterioration under an inert atmosphere at −35 °C. 
 Procedure for the preparation of a solution of ClZn–SiPh3.  An oven-dried 40-
mL vial equipped with a magnetic stir bar was charged with elemental lithium (87 mg, 12.5 
mmol, 2.5 equiv) and chlorotriphenylsilane (1.47 g, 5.0 mmol, 1.0 equiv), closed with a 
PTFE septum cap, and placed under vacuum.  The vial was refilled with argon, and this 
evacuation-refill cycle was repeated three times.  THF (10 mL) was then added via syringe, 
an argon-filled balloon was attached to the vial, and the suspension was cooled to 0 °C and 
sonicated in an ice/water bath for 2 h, allowing the final bath temperature to reach r.t. and 
forming a brownish-green slurry.  The mixture was then stirred under argon at 0 °C for 12 h.  




supernatant was removed from the residual lithium metal and filtered through a fritted funnel; 
the dark-green silyllithium was then titrated against diphenyl acetic acid. ZnCl2 (dried with 
a heat gun under high vacuum for 20 min prior to the reaction; 1.0 equiv with respect to 
titrated silyllithium) was weighed in the glovebox into an oven-dried 8-mL vial, and dry THF 
was added to form an ~1.2 M solution of ZnCl2.  Outside of the glovebox, this solution was 
added via syringe into a 40-mL vial that contained the silyllithium at 0 °C, and the reaction 
mixture was stirred at this temperature for 30 min.  After warming to r.t., the vial was 
transferred into the glovebox, and the reaction mixture was filtered by injecting it through a 
syringe filter.  The silylzinc solution was titrated using Knochel’s method for alkylzinc 
titration.31  
 General procedure for nickel-catalyzed silylations of unactivated alkyl halides.  
An oven-dried 20-mL vial equipped with a magnetic stir bar was charged with NiBr2×diglyme 
(4.9 mg, 0.014 mmol) and sealed with a PTFE septum cap.  The vial was placed under 
vacuum and refilled with nitrogen, and this evacuation-refill cycle was repeated three times.  
DMA (2.1 mL) was added via syringe, and the mixture was stirred vigorously at r.t. for 10 
min.  The alkyl bromide (0.7 mmol) was added via syringe, followed by stirring at r.t. for 5 
min.  A nitrogen-filled balloon was attached to the vial, which was then cooled to −20 °C.  
The mixture was stirred for 5 min, and then the solution of the silylzinc in THF (1.05 mmol, 
1.5 equiv) was added, the balloon was removed, the puncture hole was covered with vacuum 
grease, and the reaction mixture was stirred at −20 °C for 6–24 h.  The reaction was then 
quenched by the addition of ethanol (0.7 mL), followed by stirring for 1 min.  The mixture 
was next allowed to warm to r.t., and then it was diluted with Et2O (100 mL) and washed 
with deionized water (20 mL × 3).  The organic layer was dried over Na2SO4, filtered, and 
concentrated.  The residue was purified by flash chromatography. 
 For electrophiles that are solids or are viscous liquids: The alkyl bromide (0.70 mmol) 
was weighed into an oven-dried 20-mL vial charged with a magnetic stir bar, which was then 
placed under vacuum.  The vial was refilled with nitrogen, and this evacuation-refill cycle 
was repeated three times.  The solution of NiBr2×diglyme in DMA prepared as described 
above was added to the alkyl bromide, and the mixture was stirred vigorously at r.t. for 5 






 (4-(4-Methoxyphenyl)butan-2-yl)dimethyl(phenyl)silane (Table 2.2, Entry 1).  
The title compound was synthesized according to the General Procedure, using 2.0 mol% 
NiBr2×diglyme, from 1-(3-bromobutyl)-4-methoxybenzene (170 mg, 0.70 mmol).  Reaction 
time: 6 h.  The product was purified by column chromatography on silica gel (10®15% 
CH2Cl2/hexane).  Colorless oil. 
 First run: 167 mg (80% yield).  Second run: 164 mg (78% yield). 
 This compound was also prepared on a 4.5 mmol scale, using (1-(3-bromobutyl)-4-
methoxybenzene (1.09 g, 4.50 mmol), the silylzinc reagent (0.46 M; 14.7 mL, 6.8 mmol, 1.5 
equiv), and NiBr2×diglyme (15.9 mg, 0.045 mmol; 1.0 mol%).  Reaction time: 12 h.  The title 
compound was isolated in 81% yield (1.09 g). 
 1H NMR (500 MHz, CDCl3) δ 7.52 – 7.47 (m, 2H), 7.39 – 7.33 (m, 3H), 7.06 – 7.02 
(m, 2H), 6.84 – 6.80 (m, 2H), 3.80 (s, 3H), 2.72 (ddd, 1H, J = 14.4, 10.1, 4.8 Hz), 2.43 (ddd, 
1H, J = 13.7, 9.7, 6.8 Hz), 1.79 (dddd, 1H, J = 16.7, 9.7, 6.5, 3.2 Hz), 1.46 – 1.34 (m, 1H), 
1.05 – 1.00 (m, 3H), 0.96 – 0.87 (m, 1H), 0.26 (d, 6H, J = 4.6 Hz). 
 13C NMR (126 MHz, CDCl3) δ 157.7, 138.6, 134.9, 133.9, 129.2, 128.8, 127.6, 
113.7, 55.2, 33.91, 33.89, 18.7, 14.0, −4.7, −5.0. 
 FT-IR (film) 2952, 1512, 1246, 1112, 1038, 816, 701 cm-1. 
 MS (EI) m/z (M+) calcd for C19H26OSi: 298, found: 298. 
  
 
 1-(4-Methoxyphenyl)-4-methylpentan-3-yl)dimethyl(phenyl)silane (Table 2.2, 
Entry 2).  The title compound was synthesized according to the General Procedure, using 
5.0 mol% NiBr2×diglyme, from 1-(3-bromo-4-methylpentyl)-4-methoxybenzene (190 mg, 
0.70 mmol).  Reaction time: 24 h.  The product was purified by column chromatography on 
silica gel (0®20% CH2Cl2/hexane).  Colorless oil. 











 1H NMR (500 MHz, CDCl3) δ 7.54 – 7.50 (m, 2H), 7.37 – 7.33 (m, 3H), 6.98 – 6.93 
(m, 2H), 6.81  – 6.77 (m, 2H), 3.79 (s, 3H), 2.53 – 2.36 (m, 2H), 1.99 (ddq, 1H, J = 10.7, 6.9, 
3.5 Hz), 1.72 – 1.63 (m, 2H), 0.96 (d, 3H, J = 6.8 Hz), 0.92 – 0.87 (m, 4H), 0.34 (d, 6H, J = 
3.7 Hz). 
 13C NMR (126 MHz, CDCl3) δ 157.6, 140.1, 135.0, 133.8, 129.2, 128.6, 127.6, 
113.6, 55.2, 35.8, 32.6, 29.3, 28.6, 22.9, 21.3, −1.9, −2.7. 
 FT-IR (film) 2953, 1511, 1246, 1110, 1039, 820, 701 cm-1. 
 MS (EI) m/z (M+) calcd for C21H30OSi: 326, found: 326. 
 
 
 (1-(4-Methoxyphenyl)-4,4-dimethylpentan-3-yl)dimethyl(phenyl)silane (Table 
2.2, Entry 3).  The title compound was synthesized according to the General Procedure, 
using 5.0 mol% NiBr2×diglyme, from 1-(3-bromo-4,4-dimethylpentyl)-4-methoxybenzene 
(200 mg, 0.70 mmol).  Reaction time: 24 h.  The product was purified by column 
chromatography on silica gel (0®20% CH2Cl2/hexane).  Colorless oil. 
 First run: 161 mg (68% yield).  Second run: 161 mg (68% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.62 – 7.55 (m, 2H), 7.41 – 7.35 (m, 3H), 6.87 – 6.81 
(m, 2H), 6.80 – 6.75 (m, 2H), 3.78 (s, 3H), 2.38 (ddd, 1H, J = 13.2, 11.5, 5.9 Hz), 2.09 (ddd, 
1H, J = 13.2, 11.7, 5.6 Hz), 1.67 – 1.52 (m, 2H), 0.96 (s, 9H), 0.75 (dd, 1H, J = 4.9, 3.8 Hz), 
0.43 (s, 3H), 0.38 (s, 3H). 
 13C NMR (126 MHz, CDCl3) δ 157.6, 141.0, 135.2, 134.0, 129.1, 128.5, 127.6, 
113.6, 55.2, 38.76, 38.74, 34.8, 30.9, 30.6, 0.1, −2.0. 
 FT-IR (film) 2953, 1512, 1246, 816, 702 cm-1. 













 Dimethyl(phenyl)(1-(2-(trifluoromethyl)phenoxy)pentan-3-yl)silane (Table 2.2, 
Entry 4).  The title compound was synthesized according to the General Procedure, using 
2.0 mol% NiBr2×diglyme, from 1-((3-bromopentyl)oxy)-2-(trifluoromethyl)benzene (218 
mg, 0.70 mmol).  Reaction time: 6 h.  The product was purified by column chromatography 
on silica gel (hexane).  Colorless oil. 
 First run: 145 mg (57% yield).  Second run: 166 mg (65% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.58 – 7.52 (m, 3H), 7.43 – 7.39 (m, 1H), 7.37 – 7.33 
(m, 3H), 6.99 – 6.94 (m, 1H), 6.79 (d, 1H, J = 8.4 Hz), 3.97 – 3.92 (m, 2H), 1.99 (dtd, 1H, J 
= 14.3, 7.2, 5.1 Hz), 1.80 (ddt, 1H, J = 14.4, 8.3, 6.1 Hz), 1.61 (dqd, 1H, J = 14.0, 7.4, 5.1 
Hz), 1.46 – 1.37 (m, 1H), 1.10 (ddt, 1H, J = 8.3, 7.1, 5.1 Hz), 0.93 (t, 3H, J = 7.4 Hz), 0.33 
(d, 6H, J = 3.7 Hz). 
 13C NMR (126 MHz, CDCl3) δ 156.9 (d, J = 1.8 Hz), 138.8, 133.8, 133.1, 128.8, 
127.7, 127.0 (q, J = 5.3 Hz), 127.8 (q, J = 272.3 Hz), 119.6, 118.7 (q, J = 30.5 Hz), 112.6, 
67.9, 28.6, 22.9, 22.5, 13.8, −3.7, −4.2. 
 FT-IR (film) 2959, 1610, 1460, 1323, 1275, 1258, 1133, 1117, 1057, 1038, 830, 810, 
755, 701 cm-1. 
 MS (EI) m/z (M+) calcd for C20H25F3OSi: 366, found: 351 (M+−CH3). 
 
 
 tert-Butyl 4-(dimethyl(phenyl)silyl)piperidine-1-carboxylate (Table 2.2, Entry 
5).  The title compound was synthesized according to the General Procedure, using 2.0 mol% 
NiBr2×diglyme, from tert-butyl 4-bromopiperidine-1-carboxylate (185 mg, 0.70 mmol).  
Reaction time: 6 h.  The product was purified by column chromatography on silica gel (8:4:1 
hexane/CH2Cl2/Et2O).  Colorless oil. 











 1H NMR (500 MHz, CDCl3) δ 7.50 – 7.45 (m, 2H), 7.38 – 7.33 (m, 3H), 4.20 – 4.00 
(br, 2H), 2.64 – 2.54 (m, 2H), 1.61 – 1.52 (m, 2H), 1.44 (s, 9H), 1.36 – 1.21 (m, 2H), 0.95 – 
0.84 (m, 1H), 0.26 (s, 6H). 
 13C NMR (126 MHz, CDCl3) δ 154.9, 137.5, 133.9, 129.0, 127.8, 79.1, 45.7, 28.5, 
26.6, 23.9, −5.4. 
 FT-IR (film) 2928, 1693, 1427, 1248, 1167, 832, 809 cm-1. 
 MS (EI) m/z (M+) calcd for C18H29NO2Si: 319, found: 218 (M+−Boc). 
 
 
 N-(3-(Dimethyl(phenyl)silyl)butyl)-N-methylaniline (Table 2.2, Entry 6).  The 
title compound was synthesized according to the General Procedure, using 2.0 mol% 
NiBr2×diglyme, from N-(3-bromobutyl)-N-methylaniline (170 mg, 0.70 mmol).  Reaction 
time: 6 h.  The product was purified by column chromatography on silica gel (10®20% 
CH2Cl2/hexane).  Pale-yellow oil. 
 First run: 158 mg (76% yield).  Second run: 160 mg (77% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.54 – 7.49 (m, 2H), 7.40 – 7.33 (m, 3H), 7.23 – 7.17 
(m, 2H), 6.70 – 6.60 (m, 3H), 3.41 (ddd, 1H, J = 14.9, 10.6, 4.6 Hz), 3.19 (ddd, 1H, J = 14.5, 
10.3, 6.0 Hz), 2.86 (s, 3H), 1.81 (dddd, 1H, J = 13.8, 10.6, 6.1, 3.4 Hz), 1.37 – 1.26 (m, 1H), 
1.06 (d, 3H, J = 7.3 Hz), 0.93 – 0.85 (m, 1H), 0.28 (d, 6H, J = 2.9 Hz). 
 13C NMR (126 MHz, CDCl3) δ 149.4, 138.3, 133.9, 129.1, 128.9, 127.7, 115.9, 
112.1, 52.2, 37.9, 28.4, 17.1, 14.4, −4.7, −5.1. 
 FT-IR (film) 2953, 1600, 1506, 1248, 1112, 833, 814, 746, 701, 691 cm-1. 
 MS (EI) m/z (M+) calcd for C19H27NSi: 297, found: 297. 
 
 
 N-Butyl-N-(3-(dimethyl(phenyl)silyl)butyl)methanesulfonamide (Table 2.2, 















2.0 mol% NiBr2×diglyme, from N-(3-bromobutyl)-N-butylmethanesulfonamide (200 mg, 
0.70 mmol).  Reaction time: 6 h.  The product was purified by column chromatography on 
silica gel (25®35% Et2O/hexane).  Colorless oil. 
 First run: 192 mg (80% yield).  Second run: 182 mg (76% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.52 – 7.47 (m, 2H), 7.38 – 7.33 (m, 3H), 3.18 (ddd, 
1H, J = 14.3, 9.9, 4.6 Hz), 3.13 – 2.96 (m, 3H), 2.74 (s, 3H), 1.75 (dddd, 1H, J = 13.4, 10.1, 
6.8, 3.5 Hz), 1.52 – 1.40 (m, 2H), 1.33 – 1.20 (m, 3H), 0.99 (d, 3H, J = 7.3 Hz), 0.91 – 0.85 
(m, 4H), 0.28 (d, 6H, J = 0.7 Hz). 
 13C NMR (126 MHz, CDCl3) δ 138.0, 133.9, 129.0, 127.8, 47.4, 47.0, 38.3, 30.8, 
30.7, 19.9, 16.8, 14.0, 13.6, −4.7, −5.4. 
 FT-IR (film) 2956, 2869, 1334, 1249, 1146, 1112, 835, 816, 773, 702 cm-1. 
 MS (EI) m/z (M+) calcd for C17H31NO2SSi: 341, found: 326 (M+−CH3). 
 
 
 (1-(4-Chlorophenoxy)pentan-3-yl)dimethyl(phenyl)silane (Table 2.2, Entry 8).  
The title compound was synthesized according to the General Procedure, using 2.0 mol% 
NiBr2×diglyme, from 1-((3-bromopentyl)oxy)-4-chlorobenzene (195 mg, 0.70 mmol).  
Reaction time: 6 h.  The product was purified by column chromatography on silica gel 
(0®2% Et2O/hexane).  Colorless oil. 
 First run: 146 mg (63% yield).  Second run: 156 mg (67% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.55 – 7.50 (m, 2H), 7.39 – 7.32 (m, 3H), 7.21 – 7.16 
(m, 2H), 6.73 – 6.67 (m, 2H), 3.88 – 3.75 (m, 2H), 1.93 (dddd, 1H, J = 13.6, 8.2, 6.6, 5.1 
Hz), 1.77 (dtd, 1H, J = 13.8, 8.0, 5.7 Hz), 1.61 (dqd, 1H, J = 13.9, 7.5, 5.0 Hz), 1.44 – 1.36 
(m, 1H), 1.00 – 0.90 (m, 4H), 0.32 (d, 6H, J = 4.1 Hz). 
 13C NMR (126 MHz, CDCl3) δ 157.6, 138.8, 133.8, 129.2, 128.9, 127.8, 125.3, 
115.7, 67.9, 28.7, 23.7, 22.7, 13.9, −3.7, −4.2. 
 FT-IR (film) 2957, 1492, 1244, 823, 701 cm-1. 









 3-(Dimethyl(phenyl)silyl)butyl furan-2-carboxylate (Table 2.2, Entry 9).  The 
title compound was synthesized according to the General Procedure, using 2.0 mol% 
NiBr2×diglyme, from 3-bromobutyl furan-2-carboxylate (173 mg, 0.70 mmol).  Reaction 
time: 6 h.  The product was purified by column chromatography on silica gel (10®15% 
CH2Cl2/hexane).  Colorless oil. 
 First run: 158 mg (75% yield).  Second run: 158 mg (75% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.58 – 7.56 (m, 1H), 7.53 – 7.48 (m, 2H), 7.38 – 7.33 
(m, 3H), 7.14 (dd, 1H, J = 3.5, 0.9 Hz), 6.50 (dd, 1H, J = 3.5, 1.7 Hz), 4.40 – 4.22 (m, 2H), 
2.01 – 1.91 (m, 1H), 1.54 – 1.41 (m, 1H), 1.09 – 1.00 (m, 4H), 0.29 (d, 6H, J = 4.2 Hz). 
 13C NMR (126 MHz, CDCl3) δ 158.7, 146.1, 145.0, 137.9, 133.9, 129.0, 127.7, 
117.6, 111.7, 64.3, 30.6, 15.9, 13.9, −4.9, −5.2. 
 FT-IR (film) 2956, 1728, 1475, 1295, 1180, 1117, 833, 815, 764, 702 cm-1. 
 MS (EI) m/z (M+) calcd for C17H22O3Si: 302, found: 302. 
 
 
 3-(3-(Dimethyl(phenyl)silyl)pentyl)-1-methyl-1H-indole (Table 2.2, Entry 10).  
The title compound was synthesized according to the General Procedure, using 5.0 mol% 
NiBr2×diglyme, from 3-(3-bromopentyl)-1-methyl-1H-indole (196 mg, 0.70 mmol).  
Reaction time: 6 h.  The product was purified by column chromatography on silica gel 
(10®15% CH2Cl2/hexane).  Pale-yellow oil. 
 First run: 186 mg (79% yield).  Second run: 185 mg (79% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.57 – 7.53 (m, 2H), 7.47 (dt, 1H, J = 7.9, 0.9 Hz), 
7.40 – 7.34 (m, 3H), 7.30 – 7.27 (m, 1H), 7.24 – 7.20 (m, 1H), 7.10 – 7.07 (m, 1H), 6.72 (s, 
1H), 3.73 (s, 3H), 2.79 (dddd, 1H, J = 14.6, 10.8, 5.1, 0.9 Hz), 2.65 (dddd, 1H, J = 14.5, 10.9, 
6.0, 0.9 Hz), 1.89 (dddd, 1H, J = 13.7, 10.7, 6.0, 4.7 Hz), 1.79 – 1.62 (m, 2H), 1.56 – 1.45 











 13C NMR (126 MHz, CDCl3) δ 139.5, 137.1, 133.9, 128.7, 128.0, 127.7, 125.8, 
121.3, 119.1, 118.4, 115.7, 109.0, 32.5, 30.2, 27.1, 24.8, 22.4, 13.8, −3.5, −3.7. 
 FT-IR (film) 2955, 2929, 1484, 1472, 1426, 1376, 1325, 1247, 1111, 830, 810, 736, 
701 cm-1. 
 MS (EI) m/z (M+) calcd for C22H29NSi: 335, found: 335. 
 
 
 (4-(4-Methoxyphenyl)-2-methylbutan-2-yl)dimethyl(phenyl)silane (Table 2.3, 
Entry 1).  The title compound was synthesized according to the General Procedure, using 
10 mol% NiBr2×diglyme, from 1-(3-bromo-3-methylbutyl)-4-methoxybenzene (180 mg, 
0.70 mmol).  Reaction time: 24 h.  The product was purified by column chromatography on 
silica gel (10®20% CH2Cl2/hexane).  Colorless oil. 
 First run: 154 mg (70% yield).  Second run: 150 mg (69% yield).  The isolated 
product includes a small amount of a non-polar impurity that co-elutes with the desired 
product during column chromatography. 
 1H NMR (500 MHz, CDCl3) δ 7.56 – 7.50 (m, 2H), 7.42 – 7.33 (m, 3H), 7.07 – 7.01 
(m, 2H), 6.87 – 6.78 (m, 2H), 3.79 (s, 3H), 2.51 – 2.44 (m, 2H), 1.58 – 1.50 (m, 2H), 0.99 (s, 
6H), 0.32 (s, 6H). 
 13C NMR (126 MHz, CDCl3) δ 157.5, 137.8, 135.6, 134.5, 129.1, 128.8, 127.5, 
113.7, 55.2, 41.6, 29.2, 23.1, 20.1, −5.6. 
 FT-IR (film) 2953, 1512, 1246, 1039, 817, 770, 736, 701 cm-1. 
 MS (EI) m/z (M+) calcd for C20H28OSi: 312, found: 312. 
 
 
 Dimethyl(4-methylheptan-4-yl)(phenyl)silane (Table 2.3, Entry 2).  The title 
compound was synthesized according to the General Procedure, using 10 mol% 
NiBr2×diglyme, from 4-bromo-4-methylheptane (135 mg, 0.70 mmol).  Reaction time: 24 h.  










 First run: 94 mg (54% yield).  Second run: 92 mg (53% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.56 – 7.49 (m, 2H), 7.37 – 7.31 (m, 3H), 1.36 – 1.17 
(m, 8H), 0.91 – 0.80 (m, 9H), 0.30 (s, 6H). 
 13C NMR (126 MHz, CDCl3) δ 139.0, 134.5, 128.5, 127.4, 39.3, 24.0, 22.2, 17.5, 
15.2, –4.1. 
 FT-IR (film) 2956, 2871, 1467, 1427, 1248, 1112, 816, 767, 735, 700 cm-1. 
 MS (EI) m/z (M+) calcd for C16H28Si: 248, found: 248. 
 
 
 (3,7-Dimethyloct-6-en-3-yl)dimethyl(phenyl)silane (Table 2.3, Entry 3).  The title 
compound was synthesized according to the General Procedure, using 10 mol% 
NiBr2×diglyme, from 6-bromo-2,6-dimethyloct-2-ene (153 mg, 0.70 mmol).  Reaction time: 
24 h.  The product was purified by column chromatography on silica gel (hexane).  Colorless 
oil. 
 First run: 92 mg (48% yield).  Second run: 95 mg (49% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.56 – 7.49 (m, 2H), 7.38 – 7.30 (m, 3H), 5.08 – 5.03 
(m, 1H), 1.92 – 1.84 (m, 2H), 1.71 – 1.65 (m, 3H), 1.58 – 1.56 (m, 3H), 1.41 – 1.24 (m, 4H), 
0.89 (s, 3H), 0.81 (t, 3H, J = 7.5 Hz), 0.32 (s, 6H). 
 13C NMR (126 MHz, CDCl3) δ 138.9, 134.5, 130.8, 128.6, 127.4, 125.4, 36.0, 28.6, 
25.7, 23.8, 23.0, 21.6, 17.6, 8.7, −4.1, −4.2. 
 FT-IR (film) 2960, 1460, 1427, 1377, 1248, 1110, 830, 811, 767, 735, 701 cm-1. 
 MS (EI) m/z (M+) calcd for C18H30Si: 274, found: 274. 
 
 
 Dimethyl(1-pentylcyclobutyl)(phenyl)silane (Table 2.3, Entry 4).  The title 
compound was synthesized according to the General Procedure, using 10 mol% 









h.  The product was purified by column chromatography on silica gel (hexane).  Colorless 
oil. 
 First run: 121 mg (66% yield).  Second run: 132 mg (73% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.58 – 7.53 (m, 2H), 7.39 – 7.32 (m, 3H), 2.13 – 2.05 
(m, 2H), 1.93 – 1.76 (m, 3H), 1.70 – 1.59 (m, 1H), 1.51 – 1.42 (m, 2H), 1.31 – 1.15 (m, 6H), 
0.86 (t, 3H, J = 7.1 Hz), 0.33 (s, 6H). 
 13C NMR (126 MHz, CDCl3) δ 138.9, 134.1, 128.7, 127.5, 39.6, 32.9, 29.2, 28.3, 
25.2, 22.6, 17.2, 14.1, −4.9. 
 FT-IR (film) 2924, 2853, 1247, 1112, 815, 699 cm-1. 
 MS (EI) m/z (M+) calcd for C17H28Si: 260, found: 260. 
 
 
 Dimethyl(1-methylcyclohexyl)(phenyl)silane (Table 2.3, Entry 5).  The title 
compound was synthesized according to the General Procedure, using 10 mol% 
NiBr2×diglyme, from 1-bromo-1-methylcyclohexane (124 mg, 0.70 mmol).  Reaction time: 
24 h.  The product was purified by column chromatography on silica gel (hexane).  Colorless 
oil. 
 First run: 113 mg (69% yield).  Second run: 118 mg (72% yield).  The isolated 
product includes a small amount of a non-polar impurity that co-elutes with the desired 
product during column chromatography. 
 1H NMR (500 MHz, CDCl3) δ 7.54 – 7.48 (m, 2H), 7.38 – 7.32 (m, 3H), 1.65 – 1.56 
(m, 1H), 1.55 – 1.40 (m, 4H), 1.40 – 1.26 (m, 4H), 1.17 – 1.05 (m, 1H), 0.95 (s, 3H), 0.27 (s, 
6H). 
 13C NMR (126 MHz, CDCl3) δ 137.7, 134.7, 128.6, 127.3, 31.9, 26.7, 20.3, 20.0, 
17.9, −6.5. 
 FT-IR (film) 2916, 1426, 1246, 1106, 815, 766, 734, 699 cm-1. 









 (4-Butyltetrahydro-2H-pyran-4-yl)dimethyl(phenyl)silane (Table 2.3, Entry 6).  
The title compound was synthesized according to the General Procedure, using 2.0 mol% 
NiBr2×diglyme, from 4-bromo-4-butyltetrahydro-2H-pyran (155 mg, 0.70 mmol).  Reaction 
time: 24 h.  The product was purified by column chromatography on silica gel (5®10% 
Et2O/hexane).  Colorless oil. 
 First run: 145 mg (75% yield).  Second run: 142 mg (73% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.52 – 7.47 (m, 2H), 7.38 – 7.32 (m, 3H), 3.71 – 3.56 
(m, 4H), 1.90 – 1.79 (m, 2H), 1.61 – 1.54 (m, 2H), 1.37 – 1.30 (m, 2H), 1.28 – 1.20 (m, 2H), 
1.17 – 1.09 (m, 2H), 0.85 (t, 3H, J = 7.3 Hz), 0.32 (s, 6H). 
 13C NMR (126 MHz, CDCl3) δ 137.9, 134.5, 128.9, 127.6, 62.6, 31.5, 30.6, 27.6, 
23.8, 21.8, 14.0, −4.7. 
 FT-IR (film) 2953, 2931, 2858, 1427, 1249, 1105, 866, 826, 809, 767, 736,  
 701 cm-1. 
 MS (EI) m/z (M+) calcd for C17H28OSi: 276, found: 261 (M+−CH3). 
 
 
 (4-(4-Methoxyphenyl)butan-2-yl)dimethyl(phenyl)silane (Eq. 2.3).  The title 
compound was synthesized according to the General Procedure, using 2.0 mol% 
NiBr2×diglyme, from 1-(3-iodobutyl)-4-methoxybenzene (203 mg, 0.70 mmol).  Reaction 
time: 6 h.  The product was purified by column chromatography on silica gel (10®25% 
CH2Cl2/hexane).  Colorless oil. 
 First run: 130 mg (62% yield).  Second run: 130 mg (62% yield). 














 (Adamantan-1-yl)dimethyl(phenyl)silane (Eq. 2.4).  The title compound was 
synthesized according to the General Procedure, using 10 mol% NiBr2×diglyme, from 1-
iodoadamantane (183 mg, 0.70 mmol).  Reaction time: 24 h.  The product was purified by 
column chromatography on silica gel (hexane).  Colorless oil. 
 First run: 102 mg (54% yield).  Second run: 105 mg (56% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.51 – 7.46 (m, 2H), 7.39 – 7.33 (m, 3H), 1.84 – 1.81 
(m, 3H), 1.77 – 1.63 (m, 12H), 0.23 (s, 6H). 
 13C NMR (126 MHz, CDCl3) δ 137.2, 134.6, 128.6, 127.3, 37.5, 37.1, 27.6, 21.5, 
−7.3. 
 FT-IR (film) 2896, 2843, 1426, 1252, 1115, 852, 827, 799, 764, 733, 699 cm-1. 
 MS (ESI) m/z (M+) calcd for C18H26Si: 270, found: 270. 
 The spectral data are in agreement with literature data.32 
 
 
 (4-(4-Methoxyphenyl)butan-2-yl)(methyl)diphenylsilane (Eq. 2.5).  The title 
compound was synthesized according to the General Procedure, using 10 mol% 
NiBr2×diglyme, from 1-(3-bromobutyl)-4-methoxybenzene (170 mg, 0.70 mmol) and a 
silylzinc reagent prepared from chloro(methyl)diphenylsilane.  Reaction time: 24 h.  The 
product was purified by column chromatography on silica gel (10®20% CH2Cl2/hexane).  
Colorless oil. 
 First run: 224 mg (89% yield).  Second run: 216 mg (85% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.52 – 7.48 (m, 4H), 7.41 – 7.32 (m, 6H), 7.05 – 7.00 
(m, 2H), 6.85 – 6.80 (m, 2H), 3.81 (s, 3H), 2.76 (ddd, 1H, J = 14.0, 9.6, 4.7 Hz), 2.47 (ddd, 
1H, J = 13.7, 9.2, 7.4 Hz), 1.94 – 1.84 (m, 1H), 1.46 (dddd, 1H, J = 13.6, 10.8, 9.2, 4.7 Hz), 
1.39 – 1.30 (m, 1H), 1.10 (d, 3H, J = 7.3 Hz), 0.54 (s, 3H). 
 13C NMR (126 MHz, CDCl3) δ 157.6, 136.5, 136.3, 134.81, 134.78, 134.6, 129.4, 








 FT-IR (film) 3068, 2952, 2852, 1611, 1511, 1427, 1244, 1110, 1037, 785, 699 cm-1. 
 MS (EI) m/z (M+) calcd for C24H28OSi: 360, found: 360. 
 
 
 (4-(4-Methoxyphenyl)butan-2-yl)triphenylsilane (Eq. 2.5).  The title compound 
was synthesized according to the General Procedure, using 10 mol% NiBr2×diglyme, from 1-
(3-bromobutyl)-4-methoxybenzene (170 mg, 0.70 mmol) and a silylzinc reagent prepared 
from chlorotriphenylsilane.  Reaction time: 24 h; reaction temperature: r.t.  The product was 
purified by column chromatography on silica gel (10®20% CH2Cl2/hexane).  Colorless, 
viscous oil. 
 First run: 234 mg (79% yield).  Second run: 236 mg (80% yield). 
 1H NMR (500 MHz, CDCl3) δ 7.56 – 7.53 (m, 6H), 7.44 – 7.40 (m, 3H), 7.39 – 7.34 
(m, 6H), 7.09 – 7.05 (m, 2H), 6.88 – 6.84 (m, 2H), 3.82 (s, 3H), 2.83 (ddd, 1H, J = 13.6, 9.0, 
4.6 Hz), 2.56 (dt, 1H, J = 13.6, 8.3 Hz), 2.10 (dddd, 1H, J = 13.7, 9.0, 8.0, 2.3 Hz), 1.75 – 
1.66 (m, 1H), 1.58 – 1.48 (m, 1H), 1.25 (d, 3H, J = 7.3 Hz). 
 13C NMR (126 MHz, CDCl3) δ 157.6, 136.0, 134.5, 134.3, 129.5, 129.2, 127.7, 
113.6, 55.2, 34.0, 33.6, 15.8, 14.3. 
 FT-IR (film) 3067, 2931, 1511, 1428, 1246, 1109, 741, 700 cm-1. 
 MS (ESI) m/z (M+) calcd for C29H30OSi: 422, found: 345 (M+−C6H5). 
 
 
 (exo-Bicyclo[2.2.1]heptan-2-yl)dimethyl(phenyl)silane (Eq. 2.6) [65118-96-9].  
The title compound was synthesized according to the General Procedure, using 5.0 mol% 
NiBr2×diglyme, from exo-2-bromobicyclo[2.2.1]heptane (123 mg, 0.70 mmol).  Reaction 
time: 24 h.  The product was purified by column chromatography on silica gel (hexane).  









 The major diastereomer was determined to be the exo isomer by comparing the 1H 
NMR data with the data reported in the literature.33 Additionally, after converting the product 
mixture to the corresponding bicyclo[2.2.1]heptan-2-ol via a Fleming oxidation,34 the major 
alcohol product was confirmed to be the exo isomer by comparing with commercially 
available exo-bicyclo[2.2.1]heptan-2-ol. 
 First run: 136 mg (84% yield, exo/endo = 7:1).  Second run: 137 mg (85% yield, 
exo/endo = 7:1). 
 1H NMR (500 MHz, CDCl3) δ (major, exo) 7.57 – 7.52 (m, 2H), 7.38 – 7.35 (m, 3H), 
2.25 – 2.23 (m, 2H), 1.56 – 1.39 (m, 4H), 1.29 – 1.20 (m, 2H), 1.08 (m, 2H), 0.86 – 0.82 (m, 
1H), 0.27 (s, 3H), 0.25 (s, 3H). 
 13C NMR (126 MHz, CDCl3) δ (major, exo) 139.4, 133.9, 128.7, 127.6, 37.9, 37.8, 
36.9, 34.3, 32.7, 28.9, 28.5, –4.06, –4.10. 
 FT-IR (film) 2947, 2865, 1427, 1246, 1113, 698 cm-1. 
 MS (ESI) m/z (M+) calcd for C15H22Si: 230, found: 230. 
 
 
 (exo-Bicyclo[2.2.1]heptan-2-yl)dimethyl(phenyl)silane (Eq. 2.7) [65118-96-9].  
The title compound was synthesized according to the General Procedure, using 5.0 mol% 
catalyst loading, from endo-2-bromobicyclo[2.2.1]heptane (123 mg, 0.70 mmol).  Reaction 
time: 24 h.  The product was purified by column chromatography on silica gel (hexane).  
Colorless oil.  The diastereoselectivity was determined by GC analysis of the unpurified 
cross-coupling product. 
 First run: 121 mg (75% yield, exo/endo = 7:1).  Second run: 114 mg (71% yield, 
exo/endo = 7:1). 
 1H NMR (500 MHz, CDCl3) δ (major, exo) 7.56 – 7.52 (m, 2H), 7.38 – 7.35 (m, 3H), 
2.25 – 2.23 (m, 2H), 1.57 – 1.39 (m, 4H), 1.29 – 1.20 (m, 2H), 1.08 (m, 2H), 0.86 – 0.81 (m, 
1H), 0.27 (s, 3H), 0.25 (s, 3H). 
 13C NMR (126 MHz, CDCl3) δ (major, exo) 139.3, 133.9, 128.7, 127.6, 37.9, 37.8, 
36.9, 34.3, 32.7, 28.9, 28.5, –4.06, –4.10. 





 MS (ESI) m/z (M+) calcd for C15H22Si: 230, found: 230. 
 
 Competition Experiments (Eqs. 2.8 and 2.9).  In a nitrogen-filled glovebox, 
NiBr2×diglyme (3.5 mg, 0.010 mmol) was added to an oven-dried 4-mL vial equipped with 
a stir bar.  DMA (0.3 mL) was added to the vial, and then the vial was closed with a PTFE 
septum cap and removed from the glovebox.  The mixture was vigorously stirred at r.t. for 
10 min, and then the two alkyl bromides (0.10 mmol each) were added to the vial via syringe, 
and the mixture was stirred at r.t. for 5 min.  Next, the vial was cooled to –20 °C, and the 
reaction mixture was stirred for 5 min.  Then, a solution of the silylzinc reagent (0.060 M; 
0.33 mL, 0.020 mmol, 0.20 equiv) was added in one portion.  The reaction mixture was 
stirred at −20 °C for 4 h, and then the reaction was quenched with ethanol (0.1 mL).  n-
Tetradecane (26 µL) was added to the vial as an internal standard, and the reaction mixture 
was analyzed via GC. 
 
Effect of TEMPO 
 Entry 1 (no TEMPO): In a nitrogen-filled glovebox, NiBr2×diglyme (7.0 mg, 0.020 
mmol) was added to an oven-dried 4-mL vial equipped with a stir bar.  DMA (3.0 mL) was 
added to the vial, and then the vial was closed with a PTFE septum cap.  The mixture was 
vigorously stirred at r.t. for 10 min.  Then, the stock solution of the catalyst (0.30 mL; 0.0020 
mmol) was added to a 4-mL vial that contained the alkyl bromide (0.10 mmol) and a stir bar.  
The vial was closed with a PTFE septum cap and removed from the glovebox.  The reaction 
mixture was stirred at r.t. for 5 min, and then the vial was cooled to –20 °C and the reaction 
mixture was stirred for an additional 5 min.  A nitrogen-filled balloon was affixed to the vial.  
Next, a solution of the silylzinc reagent in THF (0.15 mmol, 1.5 equiv) was added, and the 
balloon was removed.  The reaction mixture was stirred at –20 °C for 2 h, and then the 
reaction was quenched by the addition of ethanol (0.1 mL).  The mixture was allowed to 
warm to r.t., n-tetradecane (26 µL) was added to the vial, and the reaction mixture was 
analyzed by GC. 
 Entries 2 and 3 (with TEMPO): In a nitrogen-filled glovebox, NiBr2×diglyme (7.0 
mg, 0.020 mmol) was added to an oven-dried 4-mL vial equipped with a stir bar.  DMA (3.0 




mixture was vigorously stirred at r.t. for 10 min.  Then, the stock solution of the catalyst (0.30 
mL; 0.0020 mmol) was added to a 4-mL vial that contained the alkyl bromide (0.10 mmol), 
TEMPO (1.6 mg, 0.010 mmol; or, 16 mg, 0.10 mmol), and a stir bar.  The vial was closed 
with a PTFE septum cap and removed from the glovebox.  The reaction mixture was stirred 
at r.t. for 5 min, and then the vial was cooled to –20 °C and the reaction mixture was stirred 
for an additional 5 min.  A nitrogen-filled balloon was affixed to the vial.  Next, a solution 
of the silylzinc reagent in THF (0.15 mmol, 1.5 equiv) was added, and the balloon was 
removed.  The reaction mixture was stirred at –20 °C for 2 h, and then the reaction was 
quenched by the addition of ethanol (0.1 mL).  The mixture was allowed to warm to r.t., n-
tetradecane (26 µL) was added to the vial, and the reaction mixture was analyzed by GC. 
 








2.0% NiBr2 •  diglyme
X mol% TEMPO
DMA /  THF
–20 °C, 2 h
Ar = p-anisyl
1.5 equiv Ar Me
SiMe2Ph










aYields were determined by GC analysis with the aid of a 
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